We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
+7.73%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.28%
AUM
$11.2B
AUM Growth
+$921M
Cap. Flow
+$201M
Cap. Flow %
1.79%
Top 10 Hldgs %
19.59%
Holding
393
New
24
Increased
178
Reduced
115
Closed
8

Top Sells

Rank Stock Value
1
CMD
Cantel Medical Corporation
CMD
+$52.2M
2
BRKR icon
Bruker
BRKR
+$42.9M
3
WSM icon
Williams-Sonoma
WSM
+$40.5M
4
MMM icon
3M
MMM
+$34.1M
5
SBNY
Signature Bank
SBNY
+$27.7M

Sector Composition

Rank Sector Weight
1 Technology 19.74%
2 Financials 16.42%
3 Healthcare 14.76%
4 Industrials 14.05%
5 Consumer Discretionary 10.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STZ icon
326
Constellation Brands
STZ
$22.5B
$515K ﹤0.01%
+2,200
New +$516K
EBC icon
327
Eastern Bankshares
EBC
$5.27B
$514K ﹤0.01%
+25,000
New +$530K
CARR icon
328
Carrier Global
CARR
$49.8B
$504K ﹤0.01%
10,377
+75
+0.7% +$3.35K
OGN icon
329
Organon & Co
OGN
$3.56B
$502K ﹤0.01%
+16,586
New +$546K
PYPL icon
330
PayPal
PYPL
$50.3B
$500K ﹤0.01%
1,714
SHW icon
331
Sherwin-Williams
SHW
$84.8B
$499K ﹤0.01%
1,833
+399
+28% +$109K
SMFG icon
332
Sumitomo Mitsui Financial
SMFG
$159B
$494K ﹤0.01%
71,700
+6,000
+9% +$43K
QQQ icon
333
Invesco QQQ Trust
QQQ
$436B
$480K ﹤0.01%
1,354
+77
+6% +$25.9K
OTIS icon
334
Otis Worldwide
OTIS
$27.9B
$444K ﹤0.01%
5,430
-50
-0.9% -$3.85K
VT icon
335
Vanguard Total World Stock ETF
VT
$75.3B
$438K ﹤0.01%
4,225
BSX icon
336
Boston Scientific
BSX
$68.4B
$434K ﹤0.01%
10,150
UGI icon
337
UGI
UGI
$7.87B
$428K ﹤0.01%
+9,250
New +$416K
MCHP icon
338
Microchip Technology
MCHP
$38.8B
$412K ﹤0.01%
5,500
NICE icon
339
Nice
NICE
$6.15B
$385K ﹤0.01%
1,555
SCHW
340
Charles Schwab
SCHW
$182B
$384K ﹤0.01%
5,270
TXN icon
341
Texas Instruments
TXN
$248B
$368K ﹤0.01%
1,913
+600
+46% +$112K
K
342
DELISTED
Kellanova
K
$367K ﹤0.01%
6,071
WFC icon
343
Wells Fargo
WFC
$254B
$367K ﹤0.01%
8,093
XYL icon
344
Xylem
XYL
$28.5B
$362K ﹤0.01%
3,016
DUK icon
345
Duke Energy
DUK
$101B
$356K ﹤0.01%
3,608
BEN icon
346
Franklin Resources
BEN
$16.8B
$352K ﹤0.01%
11,000
CRM icon
347
Salesforce
CRM
$154B
$351K ﹤0.01%
1,437
GNTX icon
348
Gentex
GNTX
$5.1B
$333K ﹤0.01%
+10,072
New +$349K
TRV icon
349
Travelers Companies
TRV
$81.1B
$331K ﹤0.01%
2,210
AEP icon
350
American Electric Power
AEP
$70.4B
$323K ﹤0.01%
+3,818
New +$329K

Similar funds

Boston Trust Walden's Q2 2021 Portfolio in Review

As of Q2 2021, Boston Trust Walden held 393 positions worth $11.2B, up 8.9% from $10.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Boston Trust Walden's Q2 2021 filing shows 24 new, 178 increased, 115 reduced and 8 closed positions. Its largest new stake was Helen of Troy: 132,720 shares worth $30.3M. The largest sale was Cantel Medical Corporation, an estimated $52.2M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Boston Trust Walden's largest Q2 2021 buy was Helen of Troy: 132,720 shares worth $30.3M.
  • Boston Trust Walden added most to Chemed in Q2 2021, an estimated $33.2M increase.
  • Boston Trust Walden's biggest Q2 2021 reduction was Bruker, cutting an estimated $42.9M.
  • Boston Trust Walden fully exited Cantel Medical Corporation in Q2 2021, selling an estimated $52.2M.
  • Boston Trust Walden's ten largest holdings make up 20% of its $11.2B portfolio in Q2 2021.
  • Boston Trust Walden opened 24 new positions and closed 8 in Q2 2021.
  • Boston Trust Walden's portfolio value rose 8.9% quarter-over-quarter to $11.2B.

Based on Boston Trust Walden's 13F filing for Q2 2021, filed 22 Jul 2021.